Culagbang, Rhea B.
HRN: 05-79-04 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
06/30/2022
07/07/2022
IV
88mg
Q8
Infected Retained Placenta And Unrepaired Episiotomy
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes